Hemophagocytosis in Critically Ill Adult Patients
ConditionHemophagocytosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorUniversity of Ulm
About this trial
The purpose of the study is to find out whether non-responsiveness to therapeutic recombinant human granulocyte colony-stimulation factor (rhG-CSF) is associated with hemophagocytosis in critically ill adult patients with cytopenias.
Eligibility criteria
Qualifiers
age > 18 years
critically ill adult patients
leukopenia and thrombocytopenia
rhG-CSF therapy
Disqualifiers
life expectancy < 24 hours
inclusion in other studies
trauma patients with reanimation on scene or immediately dying on hospital admission
pregnancy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
40 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov